| Entry |
|
|---|
| Name |
Fenfluramine (INN);
Ponderax (TN) |
|---|
| Product |
|
|---|
| Formula |
C12H16F3N
|
|---|
| Exact mass |
231.1235
|
|---|
| Mol weight |
231.2574
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Product (DG00103): | D07945<US> |
|
|---|
| Efficacy |
Appetite suppressant |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Metabolism |
Enzyme: CYP1A2 [HSA: 1544], CYP2B6 [HSA: 1555], CYP2D6 [HSA: 1565]; CYP2C9 [HSA: 1559], CYP2C19 [HSA: 1557], CYP3A4 [HSA: 1576], CYP3A5 [HSA: 1577]
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08AA Centrally acting antiobesity products
A08AA02 Fenfluramine
D07945 Fenfluramine (INN) <US>
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AX Other antiepileptics
N03AX26 Fenfluramine
D07945 Fenfluramine (INN) <US>
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Serotonin
HTR2
D07945 Fenfluramine (INN) <US>
Transporters
Solute carrier family
SLC6
SLC6A4 (HTT)
D07945 Fenfluramine (INN) <US>
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 16
1 C8y C 18.1300 -16.0300
2 C8x C 16.8700 -15.3300
3 C8x C 18.1300 -17.4300
4 C1b C 19.3200 -15.3300
5 C8y C 15.6100 -16.0300
6 C8x C 16.8700 -18.1300
7 C1c C 20.5800 -16.0300
8 C8x C 15.6100 -17.4300
9 C1d C 14.4200 -15.3300
10 N1b N 21.7700 -15.3300
11 C1a C 20.5800 -17.4300
12 X F 13.0900 -14.5600
13 X F 13.7900 -16.3800
14 X F 15.1900 -14.2100
15 C1b C 23.0300 -16.0300
16 C1a C 24.2200 -15.3300
BOND 16
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 5 8 2
8 5 9 1
9 7 10 1
10 7 11 1
11 9 12 1
12 9 13 1
13 9 14 1
14 10 15 1
15 15 16 1
16 6 8 1
|
|---|
